|1.||Valentini, Gabriele: 4 articles (01/2016 - 10/2010)|
|2.||Perosa, Federico: 4 articles (01/2016 - 10/2010)|
|3.||Mahler, Michael: 4 articles (04/2012 - 07/2002)|
|4.||Favoino, Elvira: 3 articles (01/2016 - 01/2013)|
|5.||Zhang, Shu-Hui: 3 articles (12/2014 - 08/2012)|
|6.||Wang, Shou-Mei: 3 articles (12/2014 - 08/2012)|
|7.||Feng, Xiao-Jun: 3 articles (12/2014 - 08/2012)|
|8.||Racanelli, Vito: 3 articles (01/2013 - 10/2010)|
|9.||Yoda, Kinya: 3 articles (06/2005 - 07/2003)|
|10.||Tomonaga, Takeshi: 3 articles (06/2005 - 07/2003)|
|1.||Systemic Scleroderma (Systemic Sclerosis)
12/01/2010 - "To determine the diagnostic sensitivity and specificity and the clinical usefulness of parallel anticentromere-A and anticentromere-B antibody (anti-CENP-A and anti-CENP-B) testing in patients with systemic sclerosis (SSc). "
07/01/2002 - "Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis."
09/01/1993 - "Two such assays are reported here as applied to the fractionation and visualization of human centromere protein (CENP-A), a centromere autoantigen associated with the rheumatic disease, systemic sclerosis. "
11/01/2015 - "The EUROLINE (IgG) Systemic Sclerosis panel test kit (which tests for Scl-70, CENP-A, CENP-B, RP11, RP155, Fib, NOR90, Th/To, PM100, PM75, Ku, PDGFR and Ro-52) was selected for the purpose of this study. "
01/01/2016 - "Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin."
01/01/2015 - "Our data demonstrate that excess CENP-A accumulates at noncentromeric locations in the human cancer genome. "
01/01/2015 - "Native CENP-A is often found overexpressed in human cancer cells and a range of human tumors. "
01/01/2012 - "CENP-A was not an independent prognostic marker in ER-negative tumors. "
05/01/2011 - "Genomic size of CENP-A domain is proportional to total alpha satellite array size at human centromeres and expands in cancer cells."
01/01/2012 - "For both ER-positive and ER-negative tumors, CENP-A was not a significant independent predictor of chemotherapy response. "
|3.||Colorectal Neoplasms (Colorectal Cancer)
07/01/2003 - "In this study, we demonstrate that the kinetochore protein CENP-A was overexpressed in all of 11 primary human colorectal cancer tissues. "
01/01/2015 - "We show this 8q24 accumulation of CENP-A can also be seen in early stage primary colorectal tumors. "
01/01/2015 - "We confirm that CENP-A is innately overexpressed in several colorectal cancer cell lines. "
06/01/2005 - "We have previously shown that CENP-A was overexpressed in primary human colorectal cancer. "
07/01/2003 - "Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer."
|4.||Hepatocellular Carcinoma (Hepatoma)
02/01/2008 - "An altered expression of CENP-A may be related to the proliferation of hepatocellular carcinoma through cell cycle regulation involving an altered bcl-2/Bax expression, that may be p53 independent."
03/01/2007 - "[Expression of centromere protein A in hepatocellular carcinoma]."
01/01/2012 - "Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells."
01/01/2011 - "ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth."
03/01/2007 - "To study the expression of centromere protein A (CENP-A) and its significance in hepatocellular carcinoma (HCC) and adjacent non-neoplastic liver tissue. "
|5.||Breast Neoplasms (Breast Cancer)
01/01/2011 - "Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast Cancer."
01/01/2012 - "Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer."
01/01/2012 - "This study was undertaken to determine if CENP-A is a prognostic factor for breast cancer patients not receiving systemic therapy or predictive of response to tamoxifen or neoadjuvant chemotherapy. "
01/01/2012 - "CENP-A was a significant independent prognostic marker for patients with ER-positive breast cancer not treated with systemic therapy but had limited predictive value in tamoxifen treated patients and was not predictive of response to neoadjuvant chemotherapy."
01/01/2012 - "mRNA levels of CENP-A and CENP-B, a centromere protein that binds independently of CENP-A, were measured in breast cancer specimens from 484 patients receiving no systemic therapy, 276 patients receiving tamoxifen, and 233 patients treated with neoadjuvant chemotherapy. "
|1.||centromere protein A
|3.||Proteins (Proteins, Gene)
|6.||Immunoglobulin G (IgG)
|1.||Drug Therapy (Chemotherapy)